Lake Oswego, Oregon Clinical Trials

A listing of Lake Oswego, Oregon clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 55 clinical trials
Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body

This phase III trial studies how well the addition of radiotherapy to the usual treatment (chemotherapy) works compared to the usual treatment alone in treating patients with esophageal and gastric cancer that has spread to a limited number of other places in the body (oligometastatic disease). Radiotherapy uses high energy …

adenocarcinoma of esophagus
folfox regimen
celiac
immunodeficiency
sprue
Clackamas Radiation Oncology Center
 (6.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +254 other locations
Expanded Access of Omidubicel for Allogeneic Transplantation in Patients With Hematological Malignancies

Omidubicel is an investigational therapy for patients with high-risk hematologic malignancies.

allogeneic transplantation
cancer
investigational treatment
hematologic malignancy
Oregon Health & Science University
 (4.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +3 other locations
A Safety Study of Oral Venetoclax in Combination With Intravenous Pembrolizumab in Adult Participants With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) With High Programmed Cell Death Ligand-1 (PD-L1) Expression

Non-Small Cell Lung Cancer (NSCLC) is a solid tumor, a disease in which cancer cells form in the tissues of the lung. It is the most common form of lung cancer, accounting for around 85% of lung cancers. The purpose of this study is to evaluate the safety and efficacy …

cancer
erbb1
blood test
measurable disease
growth factor
Providence Cancer Center Oncology and Hematology Care - Westside Portland /ID# 215497
 (7.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +38 other locations
Tipifarnib for the Treatment of Advanced Solid Tumors Lymphoma or Histiocytic Disorders With HRAS Gene Alterations a Pediatric MATCH Treatment Trial

This phase II pediatric MATCH trial studies how well tipifarnib works in treating patients with solid tumors that have spread to other places in the body (advanced), lymphoma, or histiocytic disorders that have HRAS genetic alterations. Tipifarnib may block the growth of cancer cells that have specific genetic changes in …

platelet count
antineoplastic
antineoplastic agents
hras gene
corticosteroids
Oregon Health and Science University
 (4.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +82 other locations
Transcranial Magnetic Stimulation in Progressive Supranuclear Palsy

The objective of this proposal is to investigate the effect of non-invasive repetitive cerebellar transcranial magnetic stimulation (rTMS) on motor control in progressive supranuclear (PSP). The central hypothesis is that augmenting cerebellar inhibition via cerebellar rTMS will decrease postural instability in patients with PSP by increasing functional connectivity between the …

dopamine
progressive supranuclear palsy
speech therapy
transcranial magnetic stimulation
Oregon Health & Science University
 (4.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
None

Providence Portland Medical Center
 (7.8 away) Contact site
  • 0 views
  • 19 May, 2025
  • +12 other locations
None

Providence Portland Medical Center
 (7.8 away) Contact site
  • 0 views
  • 19 May, 2025
  • +13 other locations
Clinical and Genetic Analysis of ROP

Retinopathy of Prematurity (ROP) is a vascular disease affecting the retinas (back of the eye) of low birth weight infants. Although it can be treated effectively if diagnosed early, it continues to be a leading cause of childhood blindness in the United States and throughout the world. The investigators feel …

retinopathy
premature birth
pediatric
blindness
prematurity
Oregon Health & Science University
 (4.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +4 other locations
PPMI 2.0 Clinical -Establishing a Deeply Phenotyped PD Cohort

The Parkinson Progression Marker Initiative 2.0 (PPMI 2.0) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic markers of Parkinson's disease (PD) progression in study participants with manifest PD, prodromal PD, and healthy controls The overall goal of …

parkinson's disease
modafinil
datscan
alpha-synuclein
bradykinesia
Oregon Health &Science University
 (4.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +45 other locations
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry

The ICGG Gaucher Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Gaucher disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The …

imiglucerase
gaucher disease
eliglustat
deficiency
Investigational Site Number 840080
 (5.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +220 other locations